Related Experiment Video

Updated: Jul 19, 2026

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma
06:21

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

Published on: November 19, 2019

Mitogen-activated protein kinases and chemoresistance in pancreatic cancer cells

Yupei Zhao1, Songjie Shen, Junchao Guo

  • 1Department of General Surgery, Peking Union Medical College Hospital, Beijing, China. Zhao8028@263.net

The Journal of Surgical Research
|October 24, 2006
PubMed
Abstract

Insights

Mitogen-activated protein kinases (MAPKs) influence pancreatic cancer chemoresistance. Inhibiting the extracellular signal-regulated kinase (ERK) pathway shows drug-dependent effects on chemoresistance and apoptosis signaling.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Cell Signaling

Background:

  • Chemoresistance presents a significant clinical challenge in pancreatic cancer treatment.
  • Mitogen-activated protein kinases (MAPKs) are implicated in chemoresistance across various cancer types.

Purpose of the Study:

  • To investigate the role and underlying mechanisms of MAPK signaling in mediating chemoresistance in pancreatic cancer cells.
  • To assess how pharmacological inhibition of MAPKs affects pancreatic cancer cell sensitivity to chemotherapeutic agents.

Main Methods:

  • Analysis of pharmacological inhibition of MAPKs on pancreatic cancer cell apoptosis resistance.
  • Evaluation of extracellular signal-regulated kinase (ERK) pathway activity in chemoresistant sublines.
  • Assessment of caspase-8, caspase-9, and phospho-Bcl-2 levels following pathway inhibition.

Main Results:

  • Elevated ERK activity was observed in chemoresistant pancreatic cancer sublines.
  • Inhibition of ERK with PD98059 sensitized cells to 5-fluorouracil (5-FU) but increased resistance to Adriamycin (ADM) and gemcitabine (GEM).
  • PD98059 modulated caspase-8 and caspase-9 activity and affected phospho-Bcl-2 levels, indicating complex downstream effects.

Conclusions:

  • Constitutive ERK activation may serve as a marker for chemoresistance in pancreatic cancer.
  • The impact of the ERK pathway on chemoresistance is drug-specific.
  • Evidence suggests a link between ERK signaling, caspase activation, and Bcl-2 regulation in pancreatic cancer chemoresistance.

More Related Videos

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency07:08

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on: February 2, 2024

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer06:20

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer

Published on: October 4, 2022

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...